RxDoctor Payments Data

Glenn Keiper, MD

Neurological Surgery · Eugene, ORNPI 1093732653

Payments from drug & device makers

What this record shows

This record is dominated by royalties or licence payments: $131,881 of the $153,370 with a category attached, or 86.0%. Spineart SA accounts for 79.8% of it on its own, with 10 other manufacturers making up the rest. Reporting peaked in 2019 at $54,871 and has fallen 99.9% since, to $60 in 2025. Among neurological surgery clinicians in OR with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$153,370in general payments, 2019–2025

Across 74 payments — averaging $2072.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Spineart SA$122K
  • Spineart USA Inc$19K
  • Zimmer Biomet$10K
  • Si-bone, Inc.$1K
  • Abbott$263
  • Spine Wave, Inc.$256
  • plus $524 from 5 others

What the payments were for

  • Royalty or licence$131,88186%
  • Consulting fees$1,0001%
  • Travel & lodging$13,8229%
  • Food & beverage$6,6664%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$153,370 in reported general payments places this provider in the 95th percentile of 95 neurological surgery providers in Oregon.

See all neurological surgery providers in Oregon

Medicare billing

Part B allowed, 2024
$166,754
Medicare patients
265
Services billed
682

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Oxycodone Hcl12$125

Paid to pharmacies, not to this prescriber.

Other neurological surgery in Eugene

See the full list for Oregon

Where these figures come from

Is this you, or does something look wrong? →